Effect of Perioperative Interleukin-6 and Tumor Necrosis Factor- α on Long-Term Outcomes in Locally Advanced Gastric Cancer: Results from the CLASS-01 Trial.

Zhenzhan Zhang Bin-Shu Weng Yaopeng Qiu Hao Feng Renyi Zhang Jiachen Zhang Yanfeng HuJiang YuGuoxin Li Hao Liu

Published in: Journal of immunology research (2022)

levels are negatively associated with 5-year survival outcomes in patients with locally advanced gastric cancer, indicating the potential survival benefits from perioperative anti-inflammatory treatment.

Keyphrases

locally advanced
rectal cancer
neoadjuvant chemotherapy
squamous cell carcinoma
cardiac surgery
anti inflammatory
radiation therapy
patients undergoing
phase ii study
clinical trial
rheumatoid arthritis
phase iii
study protocol
acute kidney injury
randomized controlled trial
phase ii
risk assessment